Novo Nordisk A/S

Anthropic will invest $100 million into an academy for training AI talent, working with companies to integrate artificial…

People who switched from obesity injections to Novo‘s new Wegovy pill continued to lose weight after three months,…

Two Indian nationals have been charged in federal court in Florida with an alleged conspiracy to smuggle counterfeit…

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…

This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Tuesday. Your old, origami-loving,…

Eli Lilly CEO Dave Ricks told CNBC on Monday that one-third of new GLP-1 pill patients are taking…

People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in…

Insulet is a high-quality compounder where a temporary execution issue is masking strong underlying fundamentals. Type 2 diabetes…

U.S. President Donald Trump delivers remarks on his administration’s healthcare policies, in the Oval Office at the White…

Novo Nordisk CEO Mike Doustdar on Wednesday defended the drugmaker’s decision to sue rival Eli Lilly over its…

Eli Lilly has won its first approval to sell its weight-loss drug Foundayo outside the U.S., allowing it…

Eli Lilly on Wednesday reported second-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook,…

Anthropic to invest $100 million to train AI engineer talent